Nuvation will launch two new studies of safusidenib in glioma, a global pivotal trial and a Phase II trial in the US.
MIM Anyware is designed to deliver secure, healthcare system-controlled access to the full portfolio of GE HealthCare’s MIM software solutions through a web browser, regardless of their location. The ...
Proposal Submitted to the Republic of Iraq- SIINA 9.4 EGB-AI - Session (4) Scientific Article (F)- SAMANSIC Coalition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results